PharmaCann International
Grow Group UK
About L.A. S.A.G.E.
LaSHybridThree time Cannabis Cup Winner in Amsterdam.
Dutch Bred, 
American Genetics, 
Afghani Genetics
La S.A.G.E.™ is the ideal strain for all the Sativa lovers who also like to get good production. It was introduced in the Bio-Cup and won 1st place right away. La S.A.G.E.™ is an amazing selection from our regular S.A.G.E.™ strain and a Skunk Sam male from seed. The result is a true Hybrid 60% Sativa/ 40% Indica. It produces dense flowers and it's covered in resin at the end of flowering. La S.A.G.E.™ first entry into the Cannabis Scene came when it was introduced in the Bio-Cup which was judged by the likes of Shanti Baba and Howard Marks a.k.a. Mr Nice. La S.A.G.E.™ won 1st place right away. The following summer it was introduced at the Irún Cup in the Basque country and won 2nd place for Sativa. Then it tested the highest THC of all entries at the last High Times Cannabis Cup in Amsterdam. Three entries - three wins.
Editor Note: SAGE, one of the parent strains is an acronym for: Sativa Afghani Genetic Equilibrium.
Description provided by The Seeds.
Information provided could come from a third-party source, and may not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).
About PhCann International B.V.
PharmaCann International is a leading company in the field of pharmaceutical cannabis, operating in accordance with EU GMP standards, with vertically integrated operations including, cloning, cultivating, cannabinoid API extraction, and pharmaceutical production and packaging.
Since inception, PharmaCann International has strive in its corporate social responsibility strategy to provide patients in need of products containing high-quality cannabinoids of natural origin and to disseminate knowledge about the therapeutic use of cannabinoids.
PharmaCann’s mission is make available a wide range of medical cannabis preparations for patients, who can benefit clinically, at the right time, at the right cost and for the right indication. Quality Control
PharmaCann operates in accordance with the highest standards, including GACP, GLP, GDP and ISO 9001, ISO 14001, ISO 27001 ISO 17025. and has a world-class laboratory for testing cannabinoids and research and development.
The Company’s European pharmaceutical cannabis facility has incorporated the latest growing, extraction and packaging technology as well established scientific methodologies to develop targeted medical cannabis products.
nyskholdings.com
Further National Health-Service Information on